| Literature DB >> 16819543 |
N Nakaya1, P E Hansen, I R Schapiro, L F Eplov, K Saito-Nakaya, Y Uchitomi, C Johansen.
Abstract
We conducted a population-based prospective cohort study in Denmark to investigate associations between the personality traits and cancer survival. Between 1976 and 1977, 1020 residents of the Copenhagen County completed a questionnaire eliciting information on personality traits and various health habits. The personality traits extraversion and neuroticism were measured using the short form of the Eysenck Personality Inventory. Follow-up in the Danish Cancer Registry for 1976-2002 revealed 189 incidents of primary cancer and follow-up for death from the date of the cancer diagnosis until 2005 revealed 82 deaths from all-cause in this group. A Cox proportional-hazards model was used to estimate the hazard ratios (HRs) of death from all-cause according to extraversion and neuroticism adjusting for potential confounding factors. A significant association was found between neuroticism and risk of death (HR, 2.3 (95% CI=1.1-4.7); Linear trend P=0.04) but not between extraversion and risk of death (HR, 0.9 (0.4-1.7); Linear trend P=0.34). Similar results were found when using cancer-related death. Stratification by gender revealed a strong positive association between neuroticism and the risk of death among women (Linear trend P=0.03). This study showed that neuroticism is negatively [corrected] associated with cancer survival. Further research on neuroticism and cancer survival is needed.Entities:
Mesh:
Year: 2006 PMID: 16819543 PMCID: PMC2360615 DOI: 10.1038/sj.bjc.6603244
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Demographic and medical characteristics according to extraversion and neuroticism in 189 persons diagnosed with cancer
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| No. of subjects | 59 | 77 | 53 | 81 | 59 | 49 | ||
| Age in years at cancer diagnosis, mean±s.d. | 55±8 | 54±8 | 56±7 | 0.38 | 55±8 | 55±8 | 54±8 | 0.88 |
| <0.01 | 0.03 | |||||||
| Man | 20 | 33 | 53 | 44 | 31 | 23 | ||
| Woman | 80 | 68 | 47 | 56 | 70 | 78 | ||
| 0.72 | ||||||||
| Digestive organs (excluding liver) | 12 | 10 | 6 | 9 | 9 | 12 | 0.91 | |
| Hormone-related organs | 24 | 21 | 13 | 20 | 17 | 23 | ||
| Virus and immune-related organs | 44 | 43 | 47 | 42 | 53 | 39 | ||
| Respiratory organs | 10 | 10 | 13 | 14 | 9 | 10 | ||
| Other organs | 10 | 16 | 21 | 16 | 14 | 16 | ||
| 0.69 | 0.11 | |||||||
| | 14 | 16 | 9 | 11 | 17 | 12 | ||
| Localised | 42 | 40 | 47 | 37 | 46 | 49 | ||
| Regional invasion | 3 | 10 | 13 | 15 | 3 | 6 | ||
| Distant metastasis | 17 | 13 | 13 | 20 | 14 | 6 | ||
| Unknown | 24 | 21 | 17 | 17 | 20 | 27 | ||
| 0.60 | 0.71 | |||||||
| <10 | 75 | 71 | 79 | 72 | 76 | 78 | ||
| ⩾10 | 25 | 29 | 21 | 28 | 24 | 23 | ||
| 0.83 | 0.01 | |||||||
| Yes | 85 | 88 | 87 | 88 | 95 | 76 | ||
| No | 15 | 12 | 13 | 12 | 8 | 25 | ||
| 0.12 | 0.07 | |||||||
| I, II | 19 | 16 | 28 | 27 | 19 | 10 | ||
| III, IV | 28 | 58 | 57 | 51 | 61 | 53 | ||
| V | 34 | 26 | 15 | 22 | 20 | 37 | ||
| 0.02 | 0.48 | |||||||
| Never smokers | 46 | 26 | 23 | 35 | 25 | 33 | ||
| Past smokers | 15 | 10 | 9 | 15 | 10 | 8 | ||
| Current smokers | 39 | 64 | 68 | 51 | 64 | 59 | ||
| <0.01 | 0.21 | |||||||
| 0 | 31 | 21 | 13 | 19 | 24 | 24 | ||
| 1–150 | 58 | 64 | 51 | 60 | 49 | 65 | ||
| ⩾151 | 12 | 16 | 36 | 21 | 27 | 10 | ||
|
| <0.01 | |||||||
| Normal | 81 | 82 | 89 | 0.70 | 96 | 90 | 55 | |
| Neurotic | 15 | 16 | 8 | 1 | 8 | 39 | ||
| Deviant/psychotic | 3 | 3 | 4 | 2 | 2 | 6 | ||
Including cancers of the breast, corpus uteri, ovary, and prostate.
Including cancers of the skin, non-Hodgkin's lymphoma, Hodgkin's disease, leukaemia, liver cancer, and cancer of the cervix uteri.
The social class variable is based on a classification constructed by the Social Research Institute in Denmark and is based on a combination of information on ownership of land, education, employment status, and number of subordinates. Social group I is the highest social group.
As evaluated by the physician who conducted the social-psychiatric interview.
Hazard ratios (HRs) for death from all causes and 95% confidence intervals (CIs) according to demographic and medical characteristics in 189 persons diagnosed with cancer
|
| |||||
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |||||
| Continuous variable | 189 | 6 | 82 | 1.05 (1.02–1.08) | <0.01 |
|
| |||||
| Man | 65 | 3 | 37 | 2.0 (1.3–3.0) | <0.01 |
| Woman | 124 | 9 | 45 | 1.0 (referent) | |
| Digestive organs (excluding liver) | 18 | 4 | 9 | 1.0 (referent) | |
| Hormone-related organs | 37 | 5 | 15 | 0.7 (0.3–1.5) | 0.33 |
| Virus and immune-related organs | 84 | 12 | 21 | 0.4 (0.2–0.8) | 0.01 |
| Respiratory organs | 21 | 1 | 18 | 3.7 (1.7–8.4) | <0.01 |
| Other organs | 29 | 3 | 19 | 1.5 (0.7–3.3) | 0.31 |
| | 25 | 26 | 3 | 1.0 (referent) | |
| Localised | 81 | 7 | 24 | 4.1 (1.2–14.2) | 0.02 |
| Regional invasion | 17 | 1 | 11 | 18.2 (4.9–68.1) | <0.01 |
| Distant metastasis | 27 | 0 | 27 | 52.5 (14.9–185.1) | <0.01 |
| Unknown | 39 | 6 | 17 | 6.7 (1.9–23.9) | <0.01 |
| <10 | 141 | 6 | 65 | 1.3 (0.8–2.3) | 0.28 |
| ⩾10 | 48 | 7 | 17 | 1.0 (referent) | |
| Yes | 164 | 6 | 71 | 1.0 (referent) | |
| No | 25 | 5 | 11 | 0.9 (0.5–1.6) | 0.64 |
| I, II | 38 | 4 | 15 | 1.0 (referent) | |
| III, IV | 103 | 7 | 44 | 1.0 (0.6–1.9) | 0.90 |
| V | 48 | 7 | 23 | 1.2 (0.6–2.3) | 0.57 |
| Never smokers | 59 | 9 | 15 | 1.0 (referent) | |
| Past smokers | 22 | 4 | 11 | 2.4 (1.1–5.3) | 0.02 |
| Current smokers | 108 | 4 | 56 | 2.6 (1.4–4.5) | <0.01 |
| 0 | 41 | 7 | 15 | 1.0 (referent) | |
| 1–150 | 110 | 7 | 44 | 1.1 (0.6–1.9) | 0.82 |
| ⩾151 | 38 | 3 | 23 | 2.0 (1.0–3.8) | 0.04 |
|
| |||||
| Normal | 158 | 6 | 65 | 1.0 (referent) | |
| Neurotic | 25 | 3 | 15 | 1.7 (1.0–3.0) | 0.053 |
| Deviant/psychotic | 6 | 6 | 2 | 0.7 (0.2–2.9) | 0.64 |
All hazard ratios (HRs) are given with 95% confidence intervals (CIs) in parentheses.
Including cancers of the breast, corpus uteri, ovary, and prostate.
Including cancers of the skin, non-Hodgkin's lymphoma, Hodgkin's disease, leukaemia, liver cancer, and cancer of the cervix uteri.
As evaluated by the physician who conducted the social-psychiatric interview.
Hazard ratios (HRs) and 95% confidence intervals (CIs) for risk of all-cause death according to extraversion and neuroticism in 189 persons diagnosed with cancer
|
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| |
|
| ||||||||||
| No. of death/no. of subjects | 27/59 | 29/77 | 26/53 | 35/81 | 22/59 | 25/49 | ||||
| Median survival years | 4 | 9 | 5 | 5 | 9 | 5 | ||||
| Age and sex adjusted HR | 1.0 (referent) | 0.7 (0.4–1.2) | 1.0 (0.5–1.8) | 1.0 (0.9–1.1) | 0.61 | 1.0 (referent) | 0.9 (05–1.6) | 1.5 (0.9–2.6) | 1.1 (1.0–1.2) | 0.12 |
| Multivariable adjusted HR1 | 1.0 (referent) | 0.5 (0.3–1.0) | 0.8 (0.4–1.7) | 0.9 (0.8–1.1) | 0.33 | 1.0 (referent) | 1.2 (0.6–2.1) | 2.6 (1.4–5.0) | 1.2 (1.1–1.4) | <0.01 |
| Multivariable adjusted HR2 | 1.0 (referent) | 0.6 (0.3–1.0) | 0.9 (0.4–1.7) | 0.9 (0.8–1.1) | 0.34 | 1.0 (referent) | 1.1 (0.6–2.1) | 2.3 (1.1–4.7) | 1.2 (1.0–1.3) | 0.04 |
| Multivariable adjusted HR3 | 1.0 (referent) | 0.6 (0.3–1.1) | 0.8 (0.4–1.7) | 1.0 (0.8–1.1) | 0.38 | 1.0 (referent) | 1.2 (0.6–2.2) | 2.6 (1.2–5.4) | 1.2 (1.0–1.3) | 0.02 |
| Multivariable adjusted HR4 | 1.0 (referent) | 0.5 (0.2–0.9) | 0.6 (0.3–1.3) | 0.9 (0.8–1.0) | 0.12 | 1.0 (referent) | 0.9 (0.4–1.7) | 2.2 (1.0–4.8) | 1.2 (1.0–1.4) | 0.04 |
|
| ||||||||||
| No of death/total | 8/12 | 13/25 | 16/28 | 19/36 | 11/18 | 7/11 | ||||
| Median survival years | 2 | 5 | 4 | 4 | 3 | 3 | ||||
| Multivariable adjusted HR1 | 1.0 (referent) | 1.3 (0.4–4.2) | 1.2 (0.4–4.0) | 1.0 (0.8–1.2_ | 0.99 | 1.0 (referent) | 1.6 (0.6–4.3) | 2.2 (0.6–4.3) | 1.2 (1.0–1.2) | 0.08 |
| Multivariable adjusted HR2 | 1.0 (referent) | 1.1 (0.3–3.9) | 1.2 (0.4–4.1) | 1.0 (0.8–1.2) | 0.98 | 1.0 (referent) | 1.4 (0.5–4.3) | 1.8 (0.5–7.1) | 1.2 (0.9–1.5) | 0.17 |
|
| ||||||||||
| No of death/total | 19/47 | 16/52 | 10/25 | 16/45 | 11/41 | 18/38 | ||||
| Median survival years | 7 | 11 | 9 | 9 | 9 | 7 | ||||
| Multivariable adjusted HR1 | 1.0 (referent) | 0.5 (0.2–1.2) | 0.7 (0.3–1.9) | 0.9 (0.8–1.1) | 0.18 | 1.0 (referent) | 0.7 (0.3–2.0) | 3.4 (1.4–8.6) | 1.3 (1.1–1.5) | <0.01 |
| MultivariableHR2 | 1.0 (referent) | 0.5 (0.2–1.2) | 0.7 (0.3–1.9) | 0.9 (0.8–1.1) | 0.18 | 1.0 (referent) | 0.7 (0.2–1.9) | 3.2 (1.1–8.7) | 1.2 (1.0–1.6) | 0.03 |
Multivariable HR1 was adjusted for age at cancer diagnosis (continuous variable), sex, cancer type (digestive organs, hormone-related organs, virus and immune-related organs, respiratory organs, or other organs), clinical stage (in situ, localised, regional invasion, distant metastasis, or unknown), smoking status at baseline (never smoker, past smoker, or current smoker), and alcohol consumption in grams per week at baseline (0, 1–150, or 151 or more).
Multivariable HR2 was adjusted for psychiatric status (normal, neurotic, or deviant/psychotic) in addition to variables adjusted for using multivariable HR1.
HR3 was estimated excluding 19 subjects who were diagnosed with cancer within the first 3 years from baseline and was adjusted for using the same variables as in multivariable HR2.
HR4 was estimated with cancer mortality as the end point and was adjusted for using the same variables as in multivariable HR2.
Linear trend tests were calculated by treating the personality subscales as continuous variables.